Drug Monitoring, Panel 5, Screen, Urine
Also known as: Prescription Drug Monitoring, Pain Management
Use
This test is used for urine-based drug monitoring to screen for commonly abused substances and to perform specimen validity testing. It is appropriate in contexts such as clinical monitoring, workplace drug testing, or prescription drug compliance assessment. It provides initial screening results to help detect amphetamines, barbiturates, benzodiazepines, cocaine metabolite, marijuana metabolite, methadone metabolite, opiates, oxycodone, and also assesses specimen integrity via creatinine, pH, and oxidant measurements.
Special Instructions
Not provided.
Limitations
Not provided.
Methodology
Immunoassay (Assay)
Biomarkers
Result Turnaround Time
1-2 days
Related Documents
For more information, please review the documents below
Specimen
Urine
Volume
30 mL
Minimum Volume
7 mL
Container
clinical drug test transport vial or sterile, leak‑proof urine container
Causes for Rejection
Preserved samples
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 5 days |
| Refrigerated | 7 days |
| Frozen | 30 days |
Other tests from different labs that may be relevant